JP Morgan Chase & Co’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $253K | Sell |
|
|||||
|
2025
Q2 | $262K | Sell |
|
|||||
|
2025
Q1 | $4.64M | Buy |
|
|||||
|
2024
Q4 | $180K | Sell |
|
|||||
|
2024
Q3 | $262K | Buy |
|
|||||
|
2024
Q2 | $247K | Sell |
|
|||||
|
2024
Q1 | $1.07M | Buy |
|
|||||
|
2023
Q4 | $328K | Sell |
|
|||||
|
2023
Q3 | $2.61M | Sell |
|
|||||
|
2023
Q2 | $2.61M | Sell |
|
|||||
|
2023
Q1 | $2.63M | Buy |
|
|||||
|
2022
Q4 | $2.21M | Buy |
|
|||||
|
2022
Q3 | $1.98M | Sell |
|
|||||
|
2022
Q2 | $1.42M | Buy |
|
|||||
|
2022
Q1 | $198K | Buy |
|
|||||
|
2021
Q4 | $142K | Buy |
|
|||||
|
2021
Q3 | $159K | Buy |
|
|||||
|
2021
Q2 | $210K | Buy |
|
|||||
|
2021
Q1 | $214K | Sell |
|
|||||
|
2020
Q4 | $676K | Buy |
|
|||||
|
2020
Q3 | $294K | Sell |
|
|||||
|
2020
Q2 | $376K | Sell |
|
|||||
|
2020
Q1 | $454K | Buy |
|
|||||
|
2019
Q4 | $341K | Buy |
|
|||||
|
2019
Q3 | $44K | Sell |
|
|||||
|
2019
Q2 | $806K | Sell |
|
|||||
|
2019
Q1 | $1.78M | Buy |
|
|||||
|
2018
Q4 | $727K | Buy |
|
|||||
|
2018
Q3 | $124K | Sell |
|
|||||
|
2018
Q2 | $59K | Sell |
|
|||||
|
2018
Q1 | $199K | Sell |
|
|||||
|
2017
Q4 | $283K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3K | Buy |
|